Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23200677)

1.

Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.

Fan J, Huang Y, Finoulst I, Wu HJ, Deng Z, Xu R, Xia X, Ferrari M, Shen H, Hu Y.

Cancer Lett. 2013 Jul 1;334(2):202-10. doi: 10.1016/j.canlet.2012.11.011. Epub 2012 Nov 27.

2.

Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis.

Han M, Xu J, Bi Y, Jiang M, Xu X, Liu Q, Jia J.

J Cancer Res Clin Oncol. 2013 Jan;139(1):57-65. doi: 10.1007/s00432-012-1299-7. Epub 2012 Aug 19.

PMID:
22903384
3.

Monitoring the progression of metastatic breast cancer on nanoporous silica chips.

Fan J, Deng X, Gallagher JW, Huang H, Huang Y, Wen J, Ferrari M, Shen H, Hu Y.

Philos Trans A Math Phys Eng Sci. 2012 May 28;370(1967):2433-47. doi: 10.1098/rsta.2011.0444.

4.

Melanoma inhibitory activity in melanoma diagnostics and therapy - a small protein is looming large.

Riechers A, Bosserhoff AK.

Exp Dermatol. 2014 Jan;23(1):12-4. doi: 10.1111/exd.12281. Review.

PMID:
24372647
5.

A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis.

Li M, Zhang B, Sun B, Wang X, Ban X, Sun T, Liu Z, Zhao X.

J Exp Clin Cancer Res. 2010 Aug 11;29:109. doi: 10.1186/1756-9966-29-109.

6.

Anti-cell death activity promotes pulmonary metastasis of melanoma cells.

Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC, Imai K.

Oncogene. 1997 Jun 19;14(24):2971-7.

7.

[Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].

Tuo CW, Zhang N, Liu QZ, Yang B, Wang MY.

Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):885-90. Chinese.

PMID:
19173986
8.

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.

Felding-Habermann B, Fransvea E, O'Toole TE, Manzuk L, Faha B, Hensler M.

Clin Exp Metastasis. 2002;19(5):427-36.

PMID:
12198771
9.

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.

Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA, Muschel RJ.

Cancer Res. 2004 Dec 1;64(23):8613-9.

10.

Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.

Ovrebø KM, Ellingsen C, Galappathi K, Rofstad EK.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e121-7. doi: 10.1016/j.ijrobp.2011.12.019. Epub 2012 Feb 28.

PMID:
22381901
11.

Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.

Pietrowska M, Polańska J, Suwiński R, Wideł M, Rutkowski T, Marczyk M, Domińczyk I, Ponge L, Marczak L, Polański A, Widłak P.

Int J Oncol. 2012 Jan;40(1):148-56. doi: 10.3892/ijo.2011.1186. Epub 2011 Sep 5.

PMID:
21894432
12.
13.

Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients.

Nicol GR, Han M, Kim J, Birse CE, Brand E, Nguyen A, Mesri M, FitzHugh W, Kaminker P, Moore PA, Ruben SM, He T.

Mol Cell Proteomics. 2008 Oct;7(10):1974-82. doi: 10.1074/mcp.M700476-MCP200. Epub 2008 Apr 3.

14.

Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.

Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI.

PLoS One. 2008;3(11):e3661. doi: 10.1371/journal.pone.0003661. Epub 2008 Nov 6. Erratum in: PLoS ONE. 2009;4(1). doi: 10.1371/annotation/9fbf88b3-5041-4a5e-b569-bc6c0e5f9c29. Pospisil, Pavel [added].

15.

Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.

Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe'er J.

Invest Ophthalmol Vis Sci. 2006 Mar;47(3):802-6.

16.

SOD derivatives prevent metastatic tumor growth aggravated by tumor removal.

Hyoudou K, Nishikawa M, Kobayashi Y, Ikemura M, Yamashita F, Hashida M.

Clin Exp Metastasis. 2008;25(5):531-6. doi: 10.1007/s10585-008-9165-3. Epub 2008 Mar 21.

PMID:
18357506
17.

[Monitoring changes of serum protein markers in metastatic colorectal carcinoma model].

Li ZG, Zhao L, Liu L, Ding YQ.

Zhonghua Bing Li Xue Za Zhi. 2007 Jan;36(1):48-52. Chinese.

PMID:
17374239
18.

Serum peptide profiling: identifying novel cancer biomarkers for early disease detection.

Martorella A, Robbins R.

Acta Biomed. 2007;78 Suppl 1:123-8.

PMID:
17465330
19.

Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.

Terracciano R, Pasqua L, Casadonte F, Frascà S, Preianò M, Falcone D, Savino R.

Bioconjug Chem. 2009 May 20;20(5):913-23. doi: 10.1021/bc800510f.

PMID:
19338374
20.

Melanoma inhibitory activity (MIA) as a serum marker for early detection of post-surgical relapse in melanoma patients: comparison with 5-S-cysteinyldopa.

Matsushita Y, Hatta N, Wakamatsu K, Takehara K, Ito S, Takata M.

Melanoma Res. 2002 Aug;12(4):319-23.

PMID:
12170180
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk